Inventor · disambiguated record
Martin James Inglis Andrews
Also filed as: ANDREWS MARTIN J · ANDREWS MARTIN J I · ANDREWS MARTIN JAMES INGLIS
17 granted patents·7 pending applications·59 citations·filing 2000–2018
92Inventor score
Top patents by PatentIndex Score
24 records- 0189US7915256B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Mar 29, 2011·12 cites·50 claims
- 0289US7501411B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2007·Granted Mar 10, 2009·12 cites·54 claims
- 0384US8133895B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2008·Granted Mar 13, 2012·7 cites·13 claims
- 0482US9895347B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2016·Granted Feb 20, 2018·3 cites·6 claims
- 0581US9351955B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2015·Granted May 31, 2016·3 cites·14 claims
- 0680US9133210B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2014·Granted Sep 15, 2015·4 cites·14 claims
- 0779US8012983B2Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Sep 6, 2011·4 cites·12 claims
- 0877US7893058B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 22, 2011·2 cites·55 claims
- 0976US7449544B2p21 peptidesCYCLACEL LTD·Filed 2003·Granted Nov 11, 2008·11 cites·9 claims
- 1074US10568867B2Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosisGALAPAGOS NV·Filed 2018·Granted Feb 25, 2020·1 cites·13 claims
- 1157US8148369B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2008·Granted Apr 3, 2012·0 cites·62 claims
- 1254US8173656B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted May 8, 2012·0 cites·12 claims
- 1352US8178530B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted May 15, 2012·0 cites·53 claims
- 1451US7951818B2Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2007·Granted May 31, 2011·0 cites·33 claims
- 1549US9006237B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2012·Granted Apr 14, 2015·0 cites·62 claims
- 1649US2011178067A1Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2011·Application pending·0 cites
- 1747US2006293245A1P21 derived peptides and uses thereofCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 1845US2005153894A1p21 peptidesCYCLACEL LTD·Filed 2004·Application pending·0 cites
- 1944US8138193B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted Mar 20, 2012·0 cites·12 claims
- 2044US7977352B2Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2007·Granted Jul 12, 2011·0 cites·32 claims
- 2143US2006281687A1Cyclin groove inhibitorsANDREWS MARTIN J·Filed 2006·Application pending·0 cites
- 2239US2003036628A1p21 peptidesFiled 2000·Application pending·0 cites
- 2338US2012010206A1Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseasesEDWARDS PAUL JOHN·Filed 2011·Application pending·0 cites
- 2428US2011118269A1Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseasesWIGERINCK PIET TOM BERT PAUL·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →